Safety, Tolerability, Pharmacokinetics of Intravenous RPX2014 and RPX7009 in Healthy Adult Subjects

NCT01897779 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

94

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Bacterial Infections

Interventions

DRUG: RPX7009
DRUG: RPX2014
DRUG: Placebo
DRUG: Combination RPX7009 and RPX2014

Sponsor

Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)